Mitomycin C

CAS 50-07-7 3 FDA-DMF suppliersSmall Molecule

Overview

Mitomycin C is an antineoplastic antibiotic isolated from Streptomyces caespitosus. It is used primarily for its ability to inhibit DNA synthesis, leading to cell death in certain types of cancer.

Therapeutic areas

OncologyOphthalmologyUrology

Related APIs

Flutamide
14 suppliers
Bevacizumab
2 suppliers
Paclitaxel
33 suppliers
Mirabegron
33 suppliers
Anastrozole
28 suppliers
Allopurinol
28 suppliers
Levofloxacin
27 suppliers
Capecitabine
27 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo